By Chigbu Nwaobia
The Pharmacists Council of Nigeria (PCN) has successfully completed its first surveillance audit following recertification to the ISO 9001:2015 Quality Management System (QMS) standard in January 2024, marking another milestone in the agency’s push to align Nigeria’s pharmaceutical regulation with global best practices.
The two-day exercise, held from 11–12 May 2026, was conducted by external auditors from NECA Global Certification Limited. The audit rigorously assessed PCN’s internal processes, documentation, service delivery frameworks, and compliance mechanisms to verify continued conformity with ISO 9001:2015 requirements.
The outcome reaffirmed the Council’s commitment to maintaining a structured, risk-based, and continuously improving quality management system. According to PCN officials, the surveillance audit focused on key areas including regulatory inspections, licensing and registration processes, enforcement operations, and stakeholder engagement.
Auditors examined how feedback from the 2024 recertification had been integrated into operations, and whether corrective actions from previous reviews had been effectively implemented. The successful completion signals that PCN’s systems remain robust, transparent, and responsive to both internal and external demands.
For Nigeria, a country with a population exceeding 220 million and a healthcare system under pressure from counterfeit drugs, regulatory gaps, and supply chain inefficiencies, PCN’s adherence to ISO 9001:2015 carries tangible national benefits.
First, it strengthens public trust in drug regulation. A certified QMS ensures that licensing, inspections, and enforcement follow documented, auditable procedures rather than ad hoc practices. This reduces opportunities for corruption and regulatory arbitrariness, which have long undermined confidence in the pharmaceutical ecosystem.
Second, it improves efficiency in government service delivery. ISO 9001:2015 emphasizes process optimization, data-driven decision making, and customer focus. For PCN, this translates to faster processing of licenses, clearer communication with stakeholders, and more consistent enforcement across states. In practical terms, pharmacies and drug distributors experience fewer delays and more predictable regulatory interactions.
Third, the certification enhances Nigeria’s credibility in regional and global health governance. As the country engages with bodies like the African Medicines Agency (AMA) and the World Health Organization (WHO), having a regulator with a certified QMS positions Nigeria as a reliable partner in cross-border drug safety and harmonization efforts. It also supports Nigeria’s goals under the African Continental Free Trade Area (AfCFTA), where regulatory coherence is critical for pharmaceutical trade.
For Nigeria’s pharmaceutical sector, PCN’s sustained ISO 9001:2015 certification creates a more predictable and quality-driven operating environment. Local manufacturers and importers benefit from clearer standards and streamlined regulatory pathways. A robust QMS reduces ambiguity in compliance requirements, allowing firms to plan investments, scale production, and pursue WHO prequalification with greater confidence. This is crucial as Nigeria seeks to reduce its 70% dependence on imported medicines. Distributors and retail pharmacies also gain from improved regulatory consistency. When inspection and enforcement processes are standardized, businesses face fewer arbitrary disruptions and can focus on maintaining quality, cold-chain integrity, and patient safety. For multinational companies and development partners, PCN’s certification signals a regulatory environment that aligns with international expectations. This can de-risk market entry and encourage technology transfer, local manufacturing partnerships, and clinical trial investments. Most importantly, patients stand to gain. A regulator operating under ISO 9001:2015 is better equipped to detect and remove substandard and falsified medicines from the supply chain. The direct outcome is improved drug safety, fewer treatment failures, and better health outcomes.
PCN’s successful surveillance audit does not mark the end of the journey, but it confirms that the Council is institutionalizing quality as a culture, not a one-off project. In a sector where lives depend on precision and accountability, that shift is significant.
As Nigeria works to achieve medicine security and universal health coverage, the integrity of its regulatory backbone will be decisive. With this audit, PCN has demonstrated that it is building that backbone to meet both domestic needs and international standards.
English